Medical Eponyms
Sudden collapse into unconsciousness with slow or absent pulse
Adams Stokes Syndrome
Test to detect central/secondary hypothyroidism
Free T4
Criteria for ICD placement
NYHA II-III
EF =<35%
Nonhemolytic reaction within 1-2 hours characterized by dyspnea, cough and chest tightness
TACO (Transfusion associated circulatory overload)
Medical breakthrough in 1901 that Karl Lienstater made
ABO Blood Groups
A neurological phenomenon in which one or both pupils is dilated and responds slowly or not at all to light and a near stimulus, accompanied by slow constriction and relaxation in the change from near to distant vision, and impaired accommodation
Adie's pupils
Degree of height loss from peak adult height suggesting possible osteoporosis
>=1.5 inches
Criteria for CRT
NYHA III-IV
EF =<35%
QRS > 120 mes
Most common inherited bleeding disorder
Autosomal dominant von-Willebrand disorder
Food that astronauts are prohibited before a mission
Beans
Nystagmus, intention tremor and staccato speech in MS
Charcot's triad
Size of adrenal incidentaloma requiring surgical resection
> 6 cm
5 causes of elevated BNP other than HF
MI
PE
CKD
Female
Older age
Primary therapy of polycythemia rubra vera
Phelobotomy to reduce Hb below 16.5
Who discovered blood circulation?
William Harvey
Anaemia seen in advanced hyperparathyroidism.
It is secondary to osteitis deformans.
Albright's anemia
FDA-approved hypoglycemic agents that reduce all-cause mortality in diabetics with CKD
Empagliflozin
Liraglutide
Trial that compared rate vs rhythm control in AF and what year was it?
AFFIRM (2002)
First and largest trial (A fib follow-up investigation of rhythm management), non-valvular
Name of Trial that compared liberal versus restrictive blood transfusion strategy in hip surgeries
FOCUS (Functional outcomes in cardiovascular patients undergoing surgical hip fracture repair)
In painful flexion of the spine, inability to sit without supporting the arms behind the torso in a tripod-like way.
Amoss's sign
Antibody test to confirm diagnosis of type 1 diabetes and to help predict development of type 1 diabetes
ZnT8 antibody test (Zinc transporter 8)
Drugs compared in PIONEER-HF Trial
Sacubtril/Valsartan VS Enalapril
in ADHF; 2018
at 4 and 8 weeks
Antidote for Factor Xa inhibitors
Andexanet alfa (ANNEXA-4 Trial)
*There is an ongoing Study 18-513; expected to be completed in 10/2022